Alcon logo

AlconNYSE: ALC

Profile

Sector:

Healthcare

Country:

Switzerland

IPO:

09 April 2019

Next earnings report:

16 August 2024

Last dividends:

14 May 2024

Next dividends:

N/A
$43.47 B
-4%vs. 3y high
98%vs. sector
-82%vs. 3y high
70%vs. sector
-7%vs. 3y high
58%vs. sector
-16%vs. 3y high
59%vs. sector

Price

regular market | Wed, 03 Jul 2024 13:30:00 GMT
$88.13+$0.62(+0.71%)
$2.46 B$2.52 B
$2.46 B$248.00 M

Analysts recommendations

Institutional Ownership

ALC Latest News

Alcon's Latest Equipment Breakthrough Technologies, Unity VCS and Unity CS, Receive U.S. FDA 510(k) Clearance
businesswire.com24 June 2024 Sentiment: -

GENEVA--(BUSINESS WIRE)--Alcon's Latest Equipment Breakthrough Technologies, Unity VCS and Unity CS, Receive U.S. FDA 510(k) Clearance.

Why Alcon (ALC) is a Top Momentum Stock for the Long-Term
zacks.com10 June 2024 Sentiment: -

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Reasons to Include Alcon (ALC) in Your Portfolio Right Now
zacks.com24 May 2024 Sentiment: POSITIVE

New product launches and strong solvency bode well for Alcon (ALC).

Is Alcon (ALC) Stock Outpacing Its Medical Peers This Year?
zacks.com23 May 2024 Sentiment: POSITIVE

Here is how Alcon (ALC) and CalciMedica Inc. (CALC) have performed compared to their sector so far this year.

Buy 5 Medical Instruments Stocks to Enhance Your Portfolio
zacks.com23 May 2024 Sentiment: POSITIVE

We have narrowed our search to five Medical Instruments stocks with strong potential for 2024. These stocks are: ALC, RXST, HOLX, VCYT, MASI.

3 Solid Buys From MedTech Following 2024 Guidance Raise
Zacks Investment Research15 May 2024 Sentiment: POSITIVE

The projected growth forecasts for BSX, ALGN, and ALC in 2024 make them appealing investment opportunities.

Alcon (ALC) Q1 Earnings Surpass Estimates, Margins Expand
Zacks Investment Research14 May 2024 Sentiment: POSITIVE

Alcon's first quarter results show significant growth in its franchises due to strong market conditions.

Alcon Inc. (ALC) Q1 2024 Earnings Call Transcript
Seeking Alpha14 May 2024 Sentiment: POSITIVE

Alcon Inc. (NYSE: ALC) held its Q1 2024 Earnings Conference Call on May 14, 2024 at 8:00 AM ET. Company representatives included Dan Cravens, David Endicott, and Tim Stonesifer. Various analysts from UBS, Citi, BTIG, Goldman Sachs, Wells Fargo, RBC Capital Markets, Needham & Co, Jefferies, KeyBanc Capital Markets, Mizuho Group, Redburn Atlantic, and Stifel were also present on the call. The operator welcomed all participants to the call and reminded them that it was in a listen-only mode.

Compared to Estimates, Alcon (ALC) Q1 Earnings: A Look at Key Metrics
Zacks Investment Research13 May 2024 Sentiment: POSITIVE

While examining the revenue and EPS of Alcon (ALC) can provide insight into its performance in the quarter ending March 2024, it is important to also compare certain key metrics with Wall Street expectations and the previous year's figures.

2 Intriguing Medical Stocks to Buy for Steady Growth as Earnings Approach
Zacks Investment Research13 May 2024 Sentiment: POSITIVE

In the medical industry, Alcon (ALC) and Prestige Consumer Healthcare (PBH) are two stocks worth considering for growth ahead of their upcoming quarterly earnings reports on May 14.

What type of business is Alcon?

Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under the PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

What sector is Alcon in?

Alcon is in the Healthcare sector

What industry is Alcon in?

Alcon is in the Medical Instruments & Supplies industry

What country is Alcon from?

Alcon is headquartered in Switzerland

When did Alcon go public?

Alcon initial public offering (IPO) was on 09 April 2019

What is Alcon website?

https://www.alcon.com

Is Alcon in the S&P 500?

No, Alcon is not included in the S&P 500 index

Is Alcon in the NASDAQ 100?

No, Alcon is not included in the NASDAQ 100 index

Is Alcon in the Dow Jones?

No, Alcon is not included in the Dow Jones index

When does Alcon report earnings?

The next expected earnings date for Alcon is 16 August 2024